Zealand Pharma A/S (ZEAL) 2018年CSR报告「NASDAQ」.pdf

1、Anders Stensbjerg Kristensenlives with type 1 diabetesClear path aheadZealand Pharma Corporate Social Responsibility Report 2018Company reg.no.20045078ContentsAbout this ReportWe believe in operating as a responsible company that serves broader economic,societal,and environmental interests.In additi

2、on to contributing to the sustainability of the world in which we live and work,acting responsibly will further our ability to develop meaningful and similarly sustainable relationships with customers,suppliers,investors,and key stakeholders including current and future employees.This statutory repo

3、rt on corporate social responsibility is for the financial year 2018,cf.section 99a and 99b of the Danish Financial Statements Act.This report is a supplement to the Managements review in the Annual Report 2018 covering the period January 1 December 31,2018.Corporate Social Responsibility Report 201

4、8Zealand in brief 3Our Ambition and Business Model 4Focus on Corporate Social Responsibility 5Commitment to Sustainable Development Goals 7Employees 8Diversity 11Quality 13Patients 14Environment 17Ethics 182Zealand Pharma Corporate Social Responsibility Report 2018Zealand inbriefChanging lives with

5、next generation peptide therapeutics.Find out more about Zealand on BiotechFounded in Copenhagen(HQ)in 1998,opened U.S.subsidiary 2018Leading Peptide PlatformA world leading peptide platform,with two medicines on the marketFour Late Stage ProgramsAccelerating late stage programs to launch new produc

6、ts into major markets in 2 to 4 yearsExpanding CapabilitiesTransforming into a fully integrated biopharma company with U.S.commercial organizationExperienced Team153 employees of which 87%are in R&DDual Nasdaq ListingTraded in Copenhagen and New YorkWe are passionate about changing the lives of peop